| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.007 |